DIR Fees, DIR Fees 2024, Compounding pharmacies, Retail pharmacies, Pharmacy Growth, Startup Pharmacies
The Bottom Line Pharmacy Podcast: Navigating The Legal Maze of 503B Compounding Featuring Dae Y. Lee, PharmD, Esq., CPBS
June 06, 2024
Many independent pharmacies are dealing with low reimbursements from PBMs which has forced them to look for other revenue sources. One of those sources being semaglutide! In this episode of The Bottom Line Pharmacy Podcast, we explore the world of 503B …
